CTI BioPharma raises $45M in convertible preferred stock private placement

On June 6, cancer company CTI BioPharma Corp. (NASDAQ:CTIC; Milan:CTIC) raised $45 million through the sale of 22,500 series N-3 convertible preferred shares at $2,000 in a follow-on underwritten by ...